Literature DB >> 11742911

Acceptability, reproducibility, and sensitivity of forced expiratory volumes and peak expiratory flow during bronchial challenge testing in asthmatic children.

L P Malmberg1, K Nikander, A S Pelkonen, P Syvänen, T Koljonen, T Haahtela, M Turpeinen.   

Abstract

OBJECTIVES: To compare the acceptability, reproducibility, and sensitivity of spirometric outcome measures of airway caliber during challenge testing in children.
DESIGN: FEV(1), forced expiratory volume in 0.75 s, forced expiratory volume in 0.5 s, and peak expiratory flow (PEF) were recorded during stepwise dosimetric histamine challenge tests. The responses were compared, and the reproducibility at baseline and from duplicate measurements at each challenge step was determined. PATIENTS: One hundred five children with newly diagnosed asthma, aged 5 to 10 years.
RESULTS: Compared to PEF, FEV(1) showed better baseline reproducibility (p = 0.002) and higher sensitivity (p < 0.0001) during challenge testing, determined as the change normalized to the baseline variation, while the forced expiratory volumes were not significantly different in these respects. During challenge testing in subjects with acceptable flow-volume tracings, paired recordings of FEV(1) agreed within 0.1 L in 85% and within 0.2 L in 93% of measurements. During challenge testing, the reproducibility of FEV(1) measurements was not better than that of the other indexes. Failure to exhale long enough precluded the use of FEV(1) in 16 of the children, particularly the youngest children.
CONCLUSIONS: The results demonstrated that the recently published guidelines for FEV(1) measurements during challenge tests can be applied to children. During challenge tests in asthmatic children, the advantage of the shorter fractions of forced expiratory volume was that they were more often acceptably recorded than FEV(1), while they showed as good reproducibility and were also equally sensitive in assessing changes in airway obstruction.

Entities:  

Mesh:

Year:  2001        PMID: 11742911     DOI: 10.1378/chest.120.6.1843

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  2 in total

1.  Levosalbutamol vs racemic salbutamol in the treatment of acute exacerbation of asthma.

Authors:  Ajay Punj; Ashish Prakash; Ashu Bhasin
Journal:  Indian J Pediatr       Date:  2009-11       Impact factor: 1.967

2.  Asthma symptoms in Hispanic children and daily ambient exposures to toxic and criteria air pollutants.

Authors:  Ralph J Delfino; Henry Gong; William S Linn; Edo D Pellizzari; Ye Hu
Journal:  Environ Health Perspect       Date:  2003-04       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.